InvestorsHub Logo

To infinity and beyond!

11/27/18 8:52 PM

#250025 RE: DaubersUP #250018

too bad the oral K will be part of a gig ut of business sale and we will never benefit

oh yes- one caveat- it has to work-never demonstrated in patients

Ha! the pill has never even been tested. if it even exists

JTORENCE

11/27/18 9:00 PM

#250027 RE: DaubersUP #250018

Daubers you are wrong,read the whole friggin article

Quote from the article.
"The company says monthly out-of-pocket costs for the majority of patients will be $20 or less. “Bayer will ensure that no eligible patient with TRK fusion cancer will go without this highly effective therapy,” the company said in a statement."

Amatuer17

11/28/18 6:29 AM

#250041 RE: DaubersUP #250018

First let K go to trial and then show efficacy. After 5 years, it is sitting on shelf after few trials, then talk annout next trial and then talk money.

K will stay there only will not come to market - IMO

AlanC

11/28/18 8:04 AM

#250047 RE: DaubersUP #250018

Thanks for posting the link, great .news! Anyone wondering why we continue to accumulate? IPIX is on the cutting edge with a very real potential of helping millions while at the same time creating wealth for its investors.
Keep the manipulated price at these levels and longs will continue to add as they are able. Go IPIX!!!